810 related articles for article (PubMed ID: 10914621)
1. Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study.
Li C; Samsioe G; Lidfelt J; Nerbrand C; Agardh CD;
Menopause; 2000; 7(4):273-81. PubMed ID: 10914621
[TBL] [Abstract][Full Text] [Related]
2. Hormone replacement therapy among Danish women aged 45-65 years: prevalence, determinants, and compliance.
Oddens BJ; Boulet MJ
Obstet Gynecol; 1997 Aug; 90(2):269-77. PubMed ID: 9241307
[TBL] [Abstract][Full Text] [Related]
3. Background factors influencing somatic and psychological symptoms in middle-age women with different hormonal status. A population-based study of Swedish women.
Li C; Borgfeldt C; Samsioe G; Lidfeldt J; Nerbrand C
Maturitas; 2005; 52(3-4):306-18. PubMed ID: 15967603
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with climacteric symptoms and the use of hormone replacement therapy.
Stadberg E; Mattsson LA; Milsom I
Acta Obstet Gynecol Scand; 2000 Apr; 79(4):286-92. PubMed ID: 10746844
[TBL] [Abstract][Full Text] [Related]
5. Spanish post-menopausal women's viewpoints on hormone therapy.
Castelo-Branco C; Ferrer J; Palacios S; Cornago S; Peralta S
Maturitas; 2007 Apr; 56(4):420-8. PubMed ID: 17174045
[TBL] [Abstract][Full Text] [Related]
6. Does hormone therapy increase allergic reactions and upper gastrointestinal problems? Results from a population-based study of Swedish woman. The women's health in the Lund area (WHILA) study.
Khatibi E A; Samsioe G; Li C; Lidfeldbt J; Agardh CD; Nerbrand C;
Maturitas; 2004 Aug; 48(4):438-45. PubMed ID: 15283937
[TBL] [Abstract][Full Text] [Related]
7. Health hazards in middle-aged women with cardiovascular disease: a case-control study of swedish women. the women's health in the Lund area (WHILA) study.
Shakir YA; Samsioe G; Khatibi E A; Nyberg P; Lidfeldt J; Agardh CD; Nerbrand C
J Womens Health (Larchmt); 2007 Apr; 16(3):406-14. PubMed ID: 17439385
[TBL] [Abstract][Full Text] [Related]
8. Impact of women's health initiative study on attitude and acceptance of hormone replacement therapy in Thai women attending menopause clinics.
Chaikittisilpa S; Jirapinyo M; Chaovisitsaree S; Wipatavit V; Bunyaviroch S; Kanluan B; Panyakhamlerd K; Jaisamrarn U; Taechakraichana N
J Med Assoc Thai; 2007 Apr; 90(4):628-35. PubMed ID: 17487115
[TBL] [Abstract][Full Text] [Related]
9. Side-effects of hormone replacement therapy and influence on pattern of use among women aged 45-64 years. The Norwegian Women and Cancer (NOWAC) study 1997.
Bakken K; Eggen AE; Lund E
Acta Obstet Gynecol Scand; 2004 Sep; 83(9):850-6. PubMed ID: 15315597
[TBL] [Abstract][Full Text] [Related]
10. Use of hormone replacement therapy by menopausal women in six family-practice teaching clinics in Israel.
Vinker S; Kaplan B; Yaphe J; Cohen O; Shumla V; Shapira G; Shofty I; Kitai E
Climacteric; 2003 Mar; 6(1):75-80. PubMed ID: 12725667
[TBL] [Abstract][Full Text] [Related]
11. [Attitudes toward estrogen replacement therapy. Study conducted on a sample population of women attending an ambulatory care center for the treatment of menopause].
Perrone G; Capri O; Borrello M; Galoppi P
Minerva Ginecol; 1993 Dec; 45(12):603-8. PubMed ID: 8139786
[TBL] [Abstract][Full Text] [Related]
12. Changes in attitudes, knowledge and hormone replacement therapy use: a comparative study in two random samples with 6-year interval.
Thunell L; Stadberg E; Milsom I; Mattsson LA
Acta Obstet Gynecol Scand; 2005 Apr; 84(4):395-401. PubMed ID: 15762973
[TBL] [Abstract][Full Text] [Related]
13. Life prevalence and determinants of hormone replacement therapy in women living in Porto, Portugal.
Lucas R; Barros H
Maturitas; 2007 Jul; 57(3):226-32. PubMed ID: 17293067
[TBL] [Abstract][Full Text] [Related]
14. Compliance considerations with hormone replacement therapy.
Karakoç B; Erenus M
Menopause; 1998; 5(2):102-6. PubMed ID: 9689204
[TBL] [Abstract][Full Text] [Related]
15. [Hormone replacement therapy--women's expectations and fears].
Schultz-Zehden B
Z Arztl Fortbild Qualitatssich; 2000 Apr; 94(3):180-8. PubMed ID: 10802891
[TBL] [Abstract][Full Text] [Related]
16. Women's use of hormone replacement therapy for relief of menopausal symptoms, for prevention of osteoporosis, and after hysterectomy.
Griffiths F; Convery B
Br J Gen Pract; 1995 Jul; 45(396):355-8. PubMed ID: 7612339
[TBL] [Abstract][Full Text] [Related]
17. Hormone replacement therapy use and menopausal symptoms among women participating in a behavioral lifestyle intervention.
Boraz MA; Simkin-Silverman LR; Wing RR; Meilahn EN; Kuller LH
Prev Med; 2001 Aug; 33(2 Pt 1):108-14. PubMed ID: 11493043
[TBL] [Abstract][Full Text] [Related]
18. Motives for initiation, temporary discontinuation, and permanent discontinuation of hormone replacement therapy use among Norwegian women.
Øren A
Maturitas; 2009 Sep; 64(1):33-7. PubMed ID: 19720480
[TBL] [Abstract][Full Text] [Related]
19. Factors predicting current use of hormone replacement therapy among menopausal Jewish women in Israel. The National Women's Health Interview Survey, 1998.
Merom D; Ifrah A; Cohen-Manheim I; Chinich A; Green MS
Isr Med Assoc J; 2002 Sep; 4(9):671-6. PubMed ID: 12440227
[TBL] [Abstract][Full Text] [Related]
20. The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy.
Madalinska JB; van Beurden M; Bleiker EM; Valdimarsdottir HB; Hollenstein J; Massuger LF; Gaarenstroom KN; Mourits MJ; Verheijen RH; van Dorst EB; van der Putten H; van der Velden K; Boonstra H; Aaronson NK
J Clin Oncol; 2006 Aug; 24(22):3576-82. PubMed ID: 16877724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
